nifedipine has been researched along with cilnidipine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (26.67) | 18.2507 |
| 2000's | 12 (40.00) | 29.6817 |
| 2010's | 10 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reimão, JQ; Scotti, MT; Tempone, AG | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Chibana, T; Noguchi, K; Ojiri, Y; Sakanashi, M | 1 |
| Dohmoto, H; Goto, A; Yamada, K; Yoshimoto, R | 1 |
| Hayashi, Y; Hiruma, T; Hosono, M; Kato, H; Ohnishi, H; Takata, Y; Watanabe, K | 1 |
| Dozen, M; Hayashi, Y; Hosono, M; Watanabe, K | 1 |
| Ishimitsu, T; Kawano, Y; Matsuoka, H; Minami, J; Numabe, A | 1 |
| Hisa, H; Kimura, T; Nagayama, T; Satoh, S; Suzuki-Kusaba, M; Yoshida, M | 1 |
| Hattori, Y; Irie, M; Takeda, S; Ueshiba, H | 1 |
| Karasawa, A; Kobayashi, S; Kosaka, N; Nito, M; Nomura, H; Sonoda, R; Tanaka, H; Yamaguchi, K | 1 |
| Hori, M; Horio, M; Imai, E; Moriyama, T; Sugiura, T | 1 |
| Fukuda, N; Hu, WY; Kanmatsuse, K; Su, JZ | 1 |
| Kimura, R; Nakajima, M; Uchida, S; Yamada, S | 1 |
| Fukuchi, M; Iwasaki, T; Masai, M; Naruse, H; Ohyanagi, M; Sakaki, T; Takahashi, K | 1 |
| Shigemasa, M; Takami, T | 1 |
| Shigematsu, M; Takami, T | 1 |
| Enomoto, A; Konda, T; Kondo, N; Takahara, A | 1 |
| Kanmatsuse, K; Koike, M; Kushiro, T; Otsuka, Y; Saito, F; Takahashi, A; Watanabe, N | 1 |
| Chen, ZY; Gollasch, M; Huang, Y; Ko, WH; Leung, FP; Leung, HS; Yao, X | 1 |
| Iwasaki, H; Nakamura, Y; Sugiyama, A; Takahara, A | 1 |
| Kimura, K; Konno, Y | 1 |
| Iwata, S; Koganei, H; Shoji, M | 1 |
| Chen, ZW; Fan, L; Furnary, A; Grove, KL; He, GW; Huang, Y; Xiao, XQ; Yang, Q | 1 |
| Aritomi, S; Konda, T; Yoshimura, M | 1 |
| Arakawa, K; Fujii, M; Inoki, I; Kimura, T; Konoshita, T; Makino, Y; Miyamori, I; Morikawa, N; Nakamura, H; Wakahara, S | 1 |
| Ando, K; Egi, K; Fujioka, S; Fukuda, S; Hosaka, S; Izumi-Nakaseko, H; Minh, PN; Mizoue, T; Nagasaka, S; Nakamura, Y; Sugiyama, A; Takazawa, K; Toguchi, K; Wada, T | 1 |
| Ando, K; Cao, X; Izumi-Nakaseko, H; Nakamura, Y; Saitoh, M; Sugiyama, A; Takahara, A; Wada, T; Xu, B; Zhu, B | 1 |
| Aimoto, M; Cao, X; Ishiguro, A; Nagasawa, Y; Nozaki, S; Okamura, K; Takahara, A | 1 |
| Kestur, US; Mugheirbi, NA; Saboo, S; Taylor, LS; Zemlyanov, DY | 1 |
5 trial(s) available for nifedipine and cilnidipine
| Article | Year |
|---|---|
Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard.
Topics: Autonomic Pathways; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine | 1998 |
Cilnidipine, the N- and L-type calcium channel antagonist, reduced on 24-h urinary catecholamines and C-peptide in hypertensive non-insulin-dependent diabetes mellitus.
Topics: Aged; C-Peptide; Calcium Channel Blockers; Catecholamines; Chromatography, High Pressure Liquid; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydropyridines; Dopamine; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Norepinephrine | 1999 |
Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Ankle; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brachial Artery; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Male; Nifedipine; Pulsatile Flow; Tetrazoles; Thiazepines; Treatment Outcome; Valine; Valsartan | 2003 |
Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine | 2003 |
A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.
Topics: Aged; Aged, 80 and over; Albuminuria; Biomarkers; Calcium Channel Blockers; Cardiovascular Diseases; Cross-Over Studies; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine | 2013 |
25 other study(ies) available for nifedipine and cilnidipine
| Article | Year |
|---|---|
Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.
Topics: Animals; Antiprotozoal Agents; Cell Line; Cricetinae; Dihydropyridines; Erythrocytes; Leishmania; Macaca mulatta; Mice; Parasitic Sensitivity Tests; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca++ channel blocker, and nifedipine in anesthetized dogs.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Myocardium; Nifedipine; Oxygen Consumption | 1992 |
Prolonged inhibition of vascular contraction and calcium influx by the novel 1,4-dihydropyridine calcium antagonist cinaldipine (FRC-8653).
Topics: Animals; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Dihydropyridines; In Vitro Techniques; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains; Time Factors; Vasodilator Agents | 1991 |
Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Catecholamines; Cold Temperature; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Male; Nifedipine; Rats; Rats, Inbred SHR; Time Factors | 1995 |
[Effect of cilnidipine on renal function in SHR and endothelin-induced renal dysfunction].
Topics: Acute Kidney Injury; Animals; Calcium Channel Blockers; Dihydropyridines; Diuresis; Endothelins; Hypertension; Male; Natriuresis; Nicardipine; Nifedipine; Rats; Rats, Inbred SHR; Renal Circulation | 1996 |
Effect of cilnidipine, a novel dihydropyridine Ca2+ channel blocker, on adrenal catecholamine secretion in anesthetized dogs.
Topics: Acetylcholine; Adrenal Glands; Animals; Calcium Channel Blockers; Catecholamines; Dihydropyridines; Dimethylphenylpiperazinium Iodide; Dogs; Female; Male; Muscarine; Nifedipine; Nitroprusside | 1998 |
[Effects of benidipine hydrochloride (Coniel) on blood pressure, heart rate and plasma norepinephrine concentration in spontaneously hypertensive rats].
Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Heart Rate; Hypertension; Male; Nifedipine; Norepinephrine; Rats; Rats, Inbred SHR | 1999 |
Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities.
Topics: Animals; Antibodies; Blotting, Northern; Calcium Channel Blockers; Cell Division; Cells, Cultured; Collagen; Cyclic AMP Response Element-Binding Protein; Dihydropyridines; Electrophoresis; Extracellular Matrix; Fibronectins; Gene Expression; Glomerular Mesangium; Nifedipine; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; RNA, Messenger; Thymidine; Transcription Factor AP-1; Transforming Growth Factor beta; Tritium | 2000 |
Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Animals; Calcium Channel Blockers; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Dihydropyridines; DNA; Fibroblast Growth Factor 2; Muscle, Smooth, Vascular; Nifedipine; Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
In vivo measurement of 1,4-dihydropyridine receptors in mesenteric arteries of spontaneously hypertensive rats and effect of nifedipine and cilnidipine.
Topics: Animals; Area Under Curve; Calcium Channel Blockers; Calcium Channels, L-Type; Cerebral Cortex; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Intravenous; Isradipine; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Rats; Rats, Inbred SHR; Tissue Distribution | 2002 |
Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts.
Topics: 3-Iodobenzylguanidine; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Heart; Heart Conduction System; Heart Rate; Male; Nifedipine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Sympathetic Nervous System | 2003 |
Neuroprotective effects of a dual L/N-type Ca(2+) channel blocker cilnidipine in the rat focal brain ischemia model.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cerebral Infarction; Dihydropyridines; Dose-Response Relationship, Drug; Male; Nifedipine; Rats; Rats, Sprague-Dawley | 2004 |
Different effects of L-type and L+N-type calcium channel blockers on hamster cheek pouch venules.
Topics: Animals; Arterioles; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cricetinae; Dihydropyridines; Male; Mesocricetus; Mouth Mucosa; Nifedipine; omega-Conotoxins; Regional Blood Flow; Venules | 2004 |
Cilnidipine, a slow-acting Ca2+ channel blocker, induces relaxation in porcine coronary artery: role of endothelial nitric oxide and [Ca2+]i.
Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Endothelium, Vascular; Nifedipine; Nitric Oxide; Swine; Vasodilation | 2006 |
Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs.
Topics: Anesthesia; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Dogs; Female; Heart; Heart Rate; Male; Nifedipine; Sympatholytics | 2007 |
Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles.
Topics: Animals; Arterioles; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Female; Hydronephrosis; Kidney Glomerulus; Nifedipine; omega-Conotoxins; Rats; Rats, Inbred SHR; Vasodilator Agents | 2008 |
Suppression of formalin-induced nociception by cilnidipine, a voltage-dependent calcium channel blocker.
Topics: Administration, Oral; Amines; Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cyclohexanecarboxylic Acids; Dihydropyridines; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Models, Animal; Nifedipine; omega-Conotoxins; Pain; Rats; Rats, Sprague-Dawley; Spinal Cord | 2009 |
Dual actions of cilnidipine in human internal thoracic artery: inhibition of calcium channels and enhancement of endothelial nitric oxide synthase.
Topics: Aged; Blotting, Western; Calcium Channel Blockers; Calcium Channels; Cyclic GMP; Dihydropyridines; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Nifedipine; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2011 |
L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Disease Models, Animal; Down-Regulation; Hypertension; Injections, Intravenous; Male; Nifedipine; Rats; Rats, Inbred SHR; Reflex; Renin-Angiotensin System | 2012 |
Comparison of direct effects of clinically available vasodilators; nitroglycerin, nifedipine, cilnidipine and diltiazem, on human skeletonized internal mammary harvested with ultrasonic scalpel.
Topics: Coronary Artery Bypass; Dihydropyridines; Diltiazem; Humans; In Vitro Techniques; Mammary Arteries; Nifedipine; Nitroglycerin; Vasoconstriction; Vasodilator Agents | 2016 |
Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Coronary Vasospasm; Coronary Vessels; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Male; Nicardipine; Nifedipine; Rats; Time Factors; Vasoconstriction; Vasodilator Agents; Vasopressins | 2016 |
Selectivity of Ca
Topics: Animals; Antihypertensive Agents; Aorta; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Esophageal Sphincter, Lower; Gastroesophageal Reflux; In Vitro Techniques; Male; Muscle Contraction; Nifedipine; Potassium Chloride; Rats, Wistar; Verapamil | 2018 |
Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
Topics: Chemistry, Pharmaceutical; Dihydropyridines; Drug Carriers; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Scanning; Nifedipine; Polymers; Pyrrolidines; Solubility; Vinyl Compounds; X-Ray Microtomography | 2019 |